Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?
Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts. Electronic address: mkonstam@tuftsmedicalcenter.org.
Marvin A
MA
Konstam
D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D006333:Heart Failure; D006801:Humans; D015260:Neprilysin; D011945:Receptors, Angiotensin; D013318:Stroke Volume; D013777:Tetrazoles
D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D015260:Neprilysin
angiotensin receptor blocker; angiotensin receptor-neprilysin inhibitor; angiotensin-converting-enzyme inhibitor; cardiovascular mortality; left ventricular ejection fraction